Characterisation of study population
| Characteristic | Value (N = 394)a |
|---|---|
| Age, median (range), years | 43 (20 – 82) |
| BMI, median (range) | 24.5 (14.1 – 44.9) |
| Histological type | |
| Squamous cell carcinoma | 298 (75.6) |
| Adenocarcinoma | 79 (20.0) |
| Neuroendocrine carcinoma | 13 (3.4) |
| Other | 4 (1.0) |
| Stage (FIGO 2009) | |
| IA1 | 18 (4.5) |
| IA2 | 15 (3.8) |
| IB1 | 236 (60.0) |
| IB2 | 44 (11.1) |
| IIA1 | 5 (1.2) |
| IIA2 | 2 (0.5) |
| IIB | 47 (12.0) |
| IIIA | 1 (0.3) |
| IIIB | 3 (0.8) |
| IVA | 2 (0.5) |
| IVB | 21 (5.3) |
| Type of pelvic LN staging | |
| SLNB only | 87 (22.1) |
| SLNB + PLND | 241 (61.1) |
| PLND only | 35 (8.9) |
| Debulking of pelvic LNs only | 31 (7.9) |
| Pelvic LN status | |
| Normal | 308 (78.2) |
| Macrometastases (± MIC ± ITC) | 53 (13.5) |
| Micrometastases (± ITC) | 23 (5.8) |
| Isolated tumour cells only | 10 (2.5) |
aData are presented as number (percentage) of patients unless otherwise indicated.